![Michael Solomon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Solomon
Directeur/Bestuurslid bij
PROTARA THERAPEUTICS, INC.
Vermogen: 123 225 $ op 31-05-2026
Profiel
Michael E.
Solomon was the founder of Epizyme, Inc. (2007) and served as Vice President-Discovery.
Current jobs include Independent Director at Protara Therapeutics, Inc. (2018) and Director at ValenzaBio, Inc. (2021).
Former jobs include Chief Executive Officer & Director at Ribometrix, Inc. (2017-2025), Director at ArTara Subsidiary, Inc., Principal at Millennium Pharmaceuticals, Inc., Chief Business Officer at Link Medicine Corp.
(2009-2012), Senior Associate at Banc of America Securities LLC, Venture Capital at SV Health Investors LLC (2016-2018), Chief Operating Officer at Ember Therapeutics, Inc. (2012-2015), Chief Operating Officer at Decibel Therapeutics, Inc. (2015-2016), and Vice President-Discovery at Hypnion, Inc. (2003-2007).
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Massachusetts.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 26.500 ( 0,05% ) | 123 225 $ | 31-05-2026 |
Actieve functies van Michael Solomon
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-05-2018 |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Directeur/Bestuurslid | 01-06-2021 |
Eerdere bekende functies van Michael Solomon
| Bedrijven | Functie | Einde |
|---|---|---|
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Algemeen Directeur | 09-01-2025 |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Corporate Officer/Principal | 01-12-2018 |
| DECIBEL THERAPEUTICS, INC. | Operationeel Directeur | 01-01-2016 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Operationeel Directeur | 01-01-2015 |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Corporate Officer/Principal | 01-01-2012 |
Opleiding van Michael Solomon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Health Technology |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Finance |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Health Technology |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
